Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M38.0Revenue (TTM) $M3.2Net Margin (%)-570.9Altman Z-Score-88.4
Enterprise Value $M41.3EPS (TTM) $-2.2Operating Margin %-559.3Piotroski F-Score4
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-570.8Higher ROA y-yY
Price/Book56.610-y EBITDA Growth Rate %--Quick Ratio0.3Cash flow > EarningsY
Price/Sales7.55-y EBITDA Growth Rate %--Current Ratio0.4Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-266.4Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M17.5ROIC % (ttm)--Gross Margin Increase y-yY

Gurus Latest Trades with BIOC

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BIOC is held by these investors:



BIOC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Neff Edward A.Director 2016-10-19Buy227,272$1.1102.73view
HALE DAVID FDirector 2016-10-19Buy90,909$1.1102.73view
Nall Michael W.CEO & President 2016-10-19Buy36,363$1.1102.73view
Chandler Marsha AlpertDirector 2016-10-19Buy4,545$1.1102.73view
Kennedy TimothyCFO, Sr V.P. Operations & Sec. 2016-10-19Buy36,363$1.1102.73view
HUEBNER BRUCE ADirector 2016-10-19Buy20,000$1.1102.73view
Gerhardt BruceDirector 2016-10-19Buy50,000$1.1102.73view
Singh VeenaSr VP & Sr Med Director 2016-10-19Buy10,000$1.1102.73view
ARNOLD LYLE JSR VP of R&D and CSO 2016-10-19Buy45,000$1.1102.73view
Wilson Margaret FayeDirector 2016-10-19Buy13,636$1.1102.73view

Quarterly/Annual Reports about BIOC:

    News about BIOC:

    Articles On GuruFocus.com
    Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with Bris Feb 23 2015 

    More From Other Websites
    BIOCEPT INC Files SEC form 8-K, Shareholder Director Nominations Mar 23 2017
    Biocept and OvaScience Post Gains Amid Investor Speculation Mar 23 2017
    Biocept Announces Revised Presentation Time at the 27th Annual Oppenheimer Healthcare Conference Mar 20 2017
    Biocept to Present at the 27th Annual Oppenheimer Healthcare Conference Mar 15 2017
    Couple sue pharma giant for work that led to prison in China Mar 14 2017
    Couple sue pharma giant for work that led to prison in China Mar 14 2017
    Biocept and Catalyst Pharmaceuticals Collaborate to Provide Liquid Biopsy Testing for Small Cell... Mar 14 2017
    Trump's choice for FDA has ties to Wall Street, drug makers Mar 11 2017
    Trump's choice for FDA has ties to Wall Street, drug makers Mar 11 2017
    Trump picks former FDA official to head food and drug agency Mar 10 2017
    Trump picks former FDA official to head food and drug agency Mar 10 2017
    Biocept to Present at the 29th Annual ROTH Conference Mar 08 2017
    BIOCEPT INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Mar 07 2017
    Biocept Reports Fourth Quarter and Full Year 2016 Financial Results Mar 07 2017
    Q4 2016 Biocept Inc Earnings Release - After Market Close Mar 07 2017
    Biocept to Release 2016 Fourth Quarter and Full Year Financial Results and Host Investor Conference... Feb 21 2017
    Biocept Appoints Michael Terry Senior Vice President Commercial Operations Feb 15 2017
    BIOCEPT INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits Feb 09 2017
    Biocept's CEO Issues Letter to Stockholders Feb 09 2017
    GSK warns profits to be hit by generic drugs competition Feb 08 2017

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)